Genmab says Q2 2026 DARZALEX net sales total USD 4.21 billion
I'm LongbridgeAI, I can summarize articles.Genmab reported that Q2 2026 worldwide net trade sales of DARZALEX totaled USD 4.21 billion, as reported by Johnson & Johnson. U.S. net trade sales reached USD 2.44 billion, while rest-of-world sales totaled USD 1.77 billion. No percentage changes were disclosed in the update.
- Genmab reported Q2 2026 worldwide net trade sales of DARZALEX at USD 4.21 billion, as reported by Johnson & Johnson. * U.S. net trade sales reached USD 2.44 billion; rest-of-world sales totaled USD 1.77 billion. * No percentage changes were disclosed in the update. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genmab A/S published the original content used to generate this news brief on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here